Company / Interest Expense per Share
Arcutis Biotherapeutics, Inc. Interest Expense per Share History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.43
FY2023
5-year range
$0.00 / $0.43
FY2020-FY2023
Trend
+50.7%
vs FY2022
Sector context
#12 of 43
Health Care
What the data says
At $0.43, Arcutis Biotherapeutics, Inc.'s interest expense per share ranks #32 of 43 in the Health Care sector. Increased from $0.00 to $0.43 over the past 2 years.
Based on SEC 10-K filings.
0.43 in FY2023.
Increased from $0.00 to $0.43 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#32 of 43 in Health CareTop 72% of 43This company $0.43 Sector average $9.80
▼
-95.6% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 50.7% year-over-year.
- Ranks #12 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.43 | +50.7% |
| FY2022 | $0.28 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026